The Saudi Arabia vaccine market was valued at USD 1.20 Billion in 2025, driven by the government initiatives, strategic partnerships, and advancements in healthcare infrastructure in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2026-2035, with the values likely to reach USD 1.94 Billion by 2035.
Base Year
Historical Period
Forecast Period
A growing population, coupled with increased awareness of vaccine-preventable diseases, is expected to fuel the market demand in Saudi Arabia.
As part of Vision 2030, Saudi Arabia is actively diversifying its economy by investing in high-value sectors like biopharmaceuticals, which is projected to elevate the Saudi Arabia vaccine market value in the forecast period.
The growing focus on strengthening domestic vaccine manufacturing capabilities is a significant market trend.
Compound Annual Growth Rate
4.9%
Value in USD Billion
2026-2035
*this image is indicative*
The vaccine market in Saudi Arabia is experiencing steady growth, driven by strong government support, advancement in healthcare infrastructure, and increasing public awareness of preventive care. The country is taking significant steps to localize vaccine production, reduce dependency on imports, and position itself as a regional hub for vaccine manufacturing and distribution. Moreover, as part of its Vision 2030 initiative, the Saudi government has prioritized healthcare transformation and pharmaceutical self-sufficiency, which is projected to boost market growth in the forecast period.
Strategic Investments in Vaccine Production Facilities to Drive Market Growth
Saudi Arabia is making strategic investments in vaccine production facilities as part of a national effort to improve pharmaceutical self-sufficiency. For instance, in 2023, the Saudi Authority for Industrial Cities and Technology Zones (MODON) signed a SAR 500 million (USD 133 million) investment agreement with the Vaccine Industrial Company to establish a joint venture vaccine manufacturing facility in Sudair City for Industry and Business. Such initiatives are anticipated to drive market growth in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Disease Indication
Market Breakup by Age
Market Breakup by End User
Segmentation Based on Product Type to Witness Substantial Growth
Based on the product type, the market is segmented into multivalent and monovalent vaccines. Multivalent vaccines protect against multiple strains or types of a pathogen in one shot, making them more efficient and cost-effective for national immunization programs. These vaccines are widely used in Saudi Arabia’s routine childhood vaccination schedule, contributing significantly to their market dominance. Moreover, the country's Ministry of Health favors multivalent vaccines in its bulk purchasing and public immunization campaigns to maximize coverage and efficiency.
The vaccine market in Saudi Arabia varies across regions due to differences in population, healthcare infrastructure, and local needs. The Central Region, especially Riyadh, is the center of government and healthcare planning and holds a substantial market share. Many vaccine policies and programs are managed from here, and the region has well-developed medical facilities and logistics networks. The Western Region, which includes Jeddah, Makkah, and Madinah, is also a major contributor to the vaccine market. These cities are densely populated and attract millions of pilgrims each year. As a result, there is a high demand for travel and seasonal vaccines, especially for diseases like meningitis and influenza.
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GSK plays a significant role in expanding global vaccine access, especially for diseases like HPV, meningitis, influenza, and hepatitis. It is active in public-private partnerships and global immunization initiatives, which are relevant for emerging markets like Saudi Arabia. GSK’s experience in technology transfer and local partnerships can help Saudi Arabia enhance its domestic production capabilities as it seeks to localize vaccine manufacturing under Vision 2030.
Merck is a key player in vaccines for diseases such as HPV (Gardasil), measles, mumps, rubella (MMR), and Ebola. Its investment in R&D and global clinical trials drives innovation across the sector. In Saudi Arabia, Merck’s advanced vaccines and commitment to global access align with the Kingdom’s goals of improving public health outcomes and introducing next-generation vaccines into the regional market.
Sanofi, headquartered in France, is a leading vaccine producer through its vaccine division, Sanofi Pasteur, offering immunizations for influenza, polio, rabies, and yellow fever, among others. The company is highly active in emerging markets, including Saudi Arabia, often working with governments and health organizations to increase vaccine coverage.
Pfizer Inc. is a global pharmaceutical leader, known for co-developing the first approved mRNA COVID-19 vaccine in partnership with BioNTech. The company has demonstrated a strong commitment to partnering with governments on public health initiatives, and its engagement in Saudi Arabia through supply agreements or prospective local manufacturing plays a key role in strengthening the country’s vaccine security and supporting the growth of its vaccine market.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include AstraZeneca plc, Johnson & Johnson Services, Inc., and CSL Behring.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Disease Indication |
|
| Breakup by Age |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share